Medical technology company Vivos Therapeutics received FDA 510(k) clearance for its daytime-nighttime device to treat obstructive sleep apnea.
Vivos Therapeutics develops treatments for dentofacial abnormalities, mild-to-moderate obstructive sleep apnea and snoring in adults.
The device expands the palate to open the airway and facilitate nasal breathing, according to a Jan. 4 news release. It is Vivos’ longest standing appliance and is used most among its trained dentists. The device can also be used in conjunction with other treatment modalities.
Michael Costa, DDS, has performed 1,000 dental implants using the Yomi robot.
From a lawsuit settlement being denied to new financing deals, here are six headlines to know on the dental technology…
A federal judge rejected Align Technology's proposal to settle its antitrust case for a second time Feb. 27.